tradepost.ai Logo
Newsletter InsightsSEC AnalysisAI Top20 IndexPricing
Log in
Start free trial
tradepost.ai Logo

Empowering Traders with AI

Quick Links

Newsletter InsightsSEC AnalysisPricingFAQ

Legal

Privacy PolicyCookies PolicySecurity Disclosure PolicyTerms & ConditionsDisclaimer

Copyright © 2025 Dutchcode B.V. All rights reserved.

10-Q - Drugs Made In America Acquisition Corp. (0002028614) (Filer)

Tue, May 20, 9:30 PM (34 days ago)

**Drugs Made In America Acquisition Corp. (DMAAU) Q1 2025 Financial Summary** **Financial Health and Performance:** - **Revenue:** No operational revenue generated; company is in pre-combination stage. - **Profit Margins:** Net income of $1,254,543 driven by interest earned on cash and investments held in the Trust Account, offset by general and administrative costs of $330,925. - **Cash Flow:** Net cash used in operating activities was $(251,244), primarily due to adjustments for interest earned and changes in operating assets and liabilities. Significant cash inflows from financing activities, including the sale of Units and Private Placement Units, totaling $231,400,816. - **Earnings Changes:** Net income per share was $0.05 for both redeemable and non-redeemable ordinary shares. **Key Financial Metrics and Trends:** - **Cash Position:** $923 in cash as of March 31, 2025, down from $1,351 at the end of 2024. - **Trust Account:** $232,735,468 held in the Trust Account, invested in U.S. government treasury obligations. - **Shareholder Deficit:** Total shareholders' deficit of $(7,176,350) as of March 31, 2025. - **Initial Public Offering (IPO):** Completed on January 29, 2025, raising $200,000,000 from the sale of 20,000,000 Units. Additional $30,000,000 raised from the over-allotment option. - **Private Placement:** $4,300,000 raised from the sale of 430,000 Private Placement Units to the Sponsor. **Uncertainties and Future Operations:** - **Business Combination:** Company has until May 2026 (with possible extensions) to complete an initial business combination. Failure to do so will result in liquidation and dissolution. - **Geopolitical Risks:** Ongoing global conflicts and sanctions may impact the search for a target business and the global economy. - **Going Concern:** Substantial doubt about the company's ability to continue as a going concern within one year after the date of the financial statements due to the mandatory liquidation and dissolution timeline. - **Cash Needs:** Company may need to raise additional funds to complete a business combination or redeem public shares upon completion. **Ticker:** DMAAU (Units), DMAA (Ordinary Shares), DMAAR (Rights)